News IDEXX Laboratories, Inc.

Stocks

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 00:00:00 14/11/2026 +03			5-day change	1st Jan Change
704.23 ^USD	+0.89%		+4.17%	+4.09%

11-12	IDEX Keeps Quarterly Dividend at $0.73 per Share, Payable Jan. 27, 2027, to Holders of Record Jan. 13	MT
11-05	Rising vet bills drive more Americans to pet insurance	RE

All News

Mentions Relevance

43d8620062e.at428Dy1G34hbwUko1BF-k8ONO7D9WKgS8UmBOJqnjA.Cbx6hkT-TDpzOm5S0ztwsxc5A4murzjmPKsWSJAv1FIf51eKcNNxNhMMQA

11-04	Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $700 From $665	MT
11-03	IDEXX Laboratories Delivered Strong Results Despite Lackluster Vet Visit Backdrop, UBS Says	MT
11-03	IDEXX Laboratories' Q3 Results Reflect Ability to Sustain Robust Pricing Despite Lower Vet Visits, UBS Says	MT
11-03	UBS Adjusts Price Target on IDEXX Laboratories to $700 From $627, Maintains Neutral Rating	MT
11-03	Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $800 From $740	MT
11-02	Top Midday Gainers	MT
11-02	IDEXX Laboratories, Inc. Revises Earnings Guidance for the Full Year of 2026	CI
11-02	IDEXX raises forecast, betting diagnostics can offset weak vet visits	RE
11-02	IDEXX Laboratories, Inc., Q3 2026 Earnings Call, Nov 02, 2026
11-02	IDEXX Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026	CI
11-02	IDEXX Laboratories' Q3 Comparable Earnings, Revenue Increase; 2026 Outlook Raised	MT
11-02	Earnings Flash (IDXX) IDEXX Laboratories Posts Q3 Comparable EPS $3.96, vs. FactSet Est of $3.73	MT
11-02	Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q3 Revenue $1.21B, vs. FactSet Est of $1.19B	MT
11-02	IDEXX Laboratories : Earnings snapshot Q3 2026	PU
11-02	IDEXX Laboratories Announces Third Quarter Results	BU
10-27	UBS Adjusts IDEXX Laboratories Price Target to $627 From $670, Maintains Neutral Rating	MT
10-20	Jefferies Adjusts Price Target on IDEXX Laboratories to $705 From $795	MT
10-16	JPMorgan Adjusts Price Target on IDEXX Laboratories to $750 From $775	MT
10-12	KeyBanc Initiates IDEXX Laboratories at Sector Weight	MT
10-01	IDEXX Laboratories to Release 2026 Third Quarter Financial Results	BU
09-30	IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI	MT
09-17	IDEXX Laboratories Adds Taeniid Tapeworm Detection to Parasite Testing Platform	MT
09-17	IDEXX Laboratories Expands Faecal DX Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection	CI
09-17	IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection	BU
09-16	IDEXX Laboratories, Inc. acquired CoVetAI Inc.	CI